/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
The clinical impact of improved or decreased left ventricular systolic function after the initial attack in patients with acute myocardial infarction
Event: Heart Failure 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Heart failure patient profile and outcome 1
Association of beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mid-range left ventricular ejection fraction after acute myocardial infarction
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
Angiotensin receptor blockers, compared with angiotensin-converting enzyme inhibitors, increased recurrent myocardial infarction in hypertensive patients with acute myocardial infarction
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation
Association between six-month blood pressure level and 1-year heart failure in hypertensive patients with acute myocardial infarction
Event: Heart Failure 2018
Topic: Hypertension, Other
Session: Hypertension - Other
Beta-blockers in patients with preserved left ventricular systolic function after acute myocardial infarction did not improve clinical outcomes
Event: ESC Congress 2017
Topic: Adjunctive medical therapy
Session: Beta-blockers in acute coronary syndromes: the end of a dogma?
Anticoagulation in patients with acute myocardial infarction who were presenting with atrial fibrillation improved clinical outcomes
Event: ESC Congress 2016
Topic: Thrombosis and coagulation
Session: Thrombosis and antithrombotic in acute coronary syndrome
ESC 365 is supported by
